These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 30087707)

  • 1. Knockdown of C1GalT1 inhibits radioresistance of human esophageal cancer cells through modifying β1-integrin glycosylation.
    Zhang C; Deng X; Qiu L; Peng F; Geng S; Shen L; Luo Z
    J Cancer; 2018; 9(15):2666-2677. PubMed ID: 30087707
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Altered O-glycosylation is associated with inherent radioresistance and malignancy of human laryngeal carcinoma.
    Dong X; Luo Z; Wang Y; Meng L; Duan Q; Qiu L; Peng F; Shen L
    Exp Cell Res; 2018 Jan; 362(2):302-310. PubMed ID: 29179977
    [TBL] [Abstract][Full Text] [Related]  

  • 3. C1GALT1 promotes invasive phenotypes of hepatocellular carcinoma cells by modulating integrin β1 glycosylation and activity.
    Liu CH; Hu RH; Huang MJ; Lai IR; Chen CH; Lai HS; Wu YM; Huang MC
    PLoS One; 2014; 9(8):e94995. PubMed ID: 25089569
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Up-regulation of C1GALT1 promotes breast cancer cell growth through MUC1-C signaling pathway.
    Chou CH; Huang MJ; Chen CH; Shyu MK; Huang J; Hung JS; Huang CS; Huang MC
    Oncotarget; 2015 Mar; 6(8):6123-35. PubMed ID: 25762620
    [TBL] [Abstract][Full Text] [Related]  

  • 5. C1GALT1 enhances proliferation of hepatocellular carcinoma cells via modulating MET glycosylation and dimerization.
    Wu YM; Liu CH; Huang MJ; Lai HS; Lee PH; Hu RH; Huang MC
    Cancer Res; 2013 Sep; 73(17):5580-90. PubMed ID: 23832667
    [TBL] [Abstract][Full Text] [Related]  

  • 6. C1GALT1 overexpression promotes the invasive behavior of colon cancer cells through modifying O-glycosylation of FGFR2.
    Hung JS; Huang J; Lin YC; Huang MJ; Lee PH; Lai HS; Liang JT; Huang MC
    Oncotarget; 2014 Apr; 5(8):2096-106. PubMed ID: 24758762
    [TBL] [Abstract][Full Text] [Related]  

  • 7. C1GALT1 high expression is associated with poor survival of patients with pancreatic ductal adenocarcinoma and promotes cell invasiveness through integrin α
    Kuo TC; Wu MH; Yang SH; Chen ST; Hsu TW; Jhuang JY; Liao YY; Tien YW; Huang MC
    Oncogene; 2021 Feb; 40(7):1242-1254. PubMed ID: 33420364
    [TBL] [Abstract][Full Text] [Related]  

  • 8. C1GALT1 expression predicts a favorable prognosis and suppresses malignant phenotypes via TrkA signaling in neuroblastoma.
    Lin NY; Chen ST; Chang HL; Lu MY; Yang YL; Chou SW; Lin DT; Lin KH; Jou ST; Hsu WM; Huang MC; Chang HH
    Oncogenesis; 2022 Feb; 11(1):8. PubMed ID: 35169131
    [TBL] [Abstract][Full Text] [Related]  

  • 9. C1GALT1-mediated O-glycan T antigen increase enhances the migration and invasion ability of gastric cancer cells.
    Bao X; Yu H; Chen Z; Chen W; Xiao Y; Wu X; Li Z
    Biochem Biophys Res Commun; 2024 Nov; 734():150641. PubMed ID: 39243676
    [TBL] [Abstract][Full Text] [Related]  

  • 10. C1GALT1 predicts poor prognosis and is a potential therapeutic target in head and neck cancer.
    Lin MC; Chien PH; Wu HY; Chen ST; Juan HF; Lou PJ; Huang MC
    Oncogene; 2018 Oct; 37(43):5780-5793. PubMed ID: 29930379
    [TBL] [Abstract][Full Text] [Related]  

  • 11. C1GALT1 in health and disease.
    Sun X; Zhan M; Sun X; Liu W; Meng X
    Oncol Lett; 2021 Aug; 22(2):589. PubMed ID: 34149900
    [TBL] [Abstract][Full Text] [Related]  

  • 12. C1GALT1 Seems to Promote In Vitro Disease Progression in Ovarian Cancer.
    Chou CH; Huang MJ; Liao YY; Chen CH; Huang MC
    Int J Gynecol Cancer; 2017 Jun; 27(5):863-871. PubMed ID: 28498248
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Down-Regulation of C1GALT1 Enhances the Progression of Cholangiocarcinoma through Activation of AKT/ERK Signaling Pathways.
    Khiaowichit J; Talabnin C; Dechsukhum C; Silsirivanit A; Talabnin K
    Life (Basel); 2022 Jan; 12(2):. PubMed ID: 35207462
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel mechanism for C1GALT1 in the regulation of gastric cancer progression.
    Dong X; Chen C; Deng X; Liu Y; Duan Q; Peng Z; Luo Z; Shen L
    Cell Biosci; 2021 Aug; 11(1):166. PubMed ID: 34452648
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Integrin β1 regulates the invasion and radioresistance of laryngeal cancer cells by targeting CD147.
    Li L; Dong X; Peng F; Shen L
    Cancer Cell Int; 2018; 18():80. PubMed ID: 29930482
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Unraveling the role of C1GALT1 in abnormal glycosylation and colorectal cancer progression.
    Tian H; Yu JL; Chu X; Guan Q; Liu J; Liu Y
    Front Oncol; 2024; 14():1389713. PubMed ID: 38699634
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Silencing profilin-1 inhibits gastric cancer progression via integrin β1/focal adhesion kinase pathway modulation.
    Cheng YJ; Zhu ZX; Zhou JS; Hu ZQ; Zhang JP; Cai QP; Wang LH
    World J Gastroenterol; 2015 Feb; 21(8):2323-35. PubMed ID: 25741138
    [TBL] [Abstract][Full Text] [Related]  

  • 18. C1GalT1 expression reciprocally controls tumour cell-cell and tumour-macrophage interactions mediated by galectin-3 and MGL with double impact on cancer development and progression.
    Wan Y; Adair K; Herrmann A; Shan X; Xia L; Duckworth CA; Yu LG
    Cell Death Dis; 2023 Aug; 14(8):547. PubMed ID: 37612278
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Simultaneous β1 integrin-EGFR targeting and radiosensitization of human head and neck cancer.
    Eke I; Zscheppang K; Dickreuter E; Hickmann L; Mazzeo E; Unger K; Krause M; Cordes N
    J Natl Cancer Inst; 2015 Feb; 107(2):. PubMed ID: 25663685
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Update on the role of C1GALT1 in cancer.
    Xia T; Xiang T; Xie H
    Oncol Lett; 2022 Mar; 23(3):97. PubMed ID: 35154428
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.